Professor of Ophthalmology, Joslin Diabetes Center, Harvard Medical School
Ophthalmology
Dr. Lloyd P. Aiello, MD
|
|
Give Review
Lloyd Aiello is an expert in the field of Ophthalmology. He studied medicine at Boston University School of Medicine. Boston University School of Medicine is ranked 30/52 in Research/PrimaryCare. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FAAO)". Lloyd P. Aiello is a published doctor. He published 61 publications, including: 'Observation of Gravitational Waves from a Binary Black Hole Merger.'
Publications
- Proteomic Analysis of Embryonic and Young Human Vitreous.
- Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology o...
- Automated retinal image analysis for Diabetic retinopathy in telemedicine.
- Telemedicine and Eye Examinations for Diabetic Retinopathy: A Time to Maximize Real-World Outcomes.
- Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4Â Years.
- Neural Retinal Disorganization as a Robust Marker of Visual Acuity in Current and Resolved Diabetic Macular Edema.
- Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic Macular edema.
- VISUAL OUTCOMES FROM PARS PLANA VITRECTOMY VERSUS COMBINED PARS PLANA VITRECTOMY, PHACOEMULSIFICATION, AND INTRAOCULAR Lens IMPLANTATION IN PATIENTS WITH DIABETES.
- Influence of diabetes and diabetes type on anatomic and visual outcomes following Central rein vein occlusion.
- Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
- Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on Diabetic retinopathy severity.
- Potential Efficiency Benefits of Nonmydriatic Ultrawide Field Retinal Imaging in an Ocular Telehealth Diabetic Retinopathy Program.
- Green or yellow laser treatment for diabetic Macular edema: exploratory assessment within the Diabetic Retinopathy Clinical Research Network.
- Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative Diabetic retinopathy.
- THE EFFECT OF THE ORAL PKC ? INHIBITOR RUBOXISTAURIN ON VISION LOSS IN TWO PHASE 3 STUDIES.
- Ultra-wide Field Retinal Imaging in Detection, Classification, and Management of Diabetic Retinopathy.
- Comparison of Low-Light Nonmydriatic Digital Imaging with 35-mm ETDRS Seven-Standard Field Stereo Color Fundus Photographs and Clinical Examination.
- Automated Retinal Imaging System (ARIS) Compared with ETDRS Protocol Color Stereoscopic Retinal Photography to Assess Level of Diabetic Retinopathy.
- Antiangiogenic therapy for ischemic retinopathies.
- Response to Comment on: Sun et al. Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration: The Joslin 50-Year Medalis...
- Vitreous levels of soluble vascular endothelial growth factor receptor (VEGFR)-1 in Eyes with vitreoretinal diseases.
- Nonmydriatic Retinal Image Review at Time of Endocrinology Visit Results in Short-Term HbA1c Reduction in Poorly Controlled Patients with Diabetic Retinopathy.
- Comparison of film and digital fundus photographs in Eyes of individuals with diabetes mellitus.
- Protection from retinopathy and Other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
- Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.
- Factors associated with visual acuity outcomes after vitrectomy for diabetic Macular edema: diabetic retinopathy clinical research network.
- Histopathology of Neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection.
- Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic Macular edema.
- Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and Diabetic retinopathy.
- Diabetes complications and the renin-angiotensin system.
- Role of steroids in the management of diabetic Macular edema and proliferative diabetic retinopathy.
- Targeting intraocular Neovascularization and edema--one drop at a time.
- Can OCT serve as a surrogate for visual acuity in Eyes with DME?
- Characterization of the vitreous proteome in diabetes without Diabetic retinopathy and diabetes with proliferative Diabetic retinopathy.
- Rosiglitazone and delayed onset of proliferative Diabetic retinopathy.
- Glypican 4, a membrane binding protein for bactericidal/permeability-increasing protein signaling pathways in retinal pigment epithelial cells.
- Clinical factors associated with resistance to microvascular complications in Diabetic patients of extreme disease duration: the 50-year medalist study.
- Short-term effects of intravitreal bevacizumab for subfoveal Choroidal neovascularization in pathologic myopia.
- Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation.
- Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects.
- Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on Edema and weight ...
- Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics.
- Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients.
- Effect of ruboxistaurin on blood-retinal barrier permeability in relation to severity of leakage in diabetic Macular edema.
- Angiogenic pathways in Diabetic retinopathy.
- Congenital retinal macrovessel.
- Risks of intravitreous injection: a comprehensive review.
- Diabetic retinopathy.
- Evolving guidelines for intravitreous injections.
- Bifunctional properties of peroxisome proliferator-activated receptor gamma1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3.
- Suppression of Fas-FasL-induced endothelial cell apoptosis prevents Diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes.
- The potential role of PKC beta in diabetic retinopathy and Macular edema.
- Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhi...
- Pigment epithelium-derived factor suppresses ischemia-induced retinal Neovascularization and VEGF-induced migration and growth.
- Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal Neovascularization and retinal pericyte growth.
- Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and Diabetic States: a possible explanation for impaired coll...
- Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proli...
- Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-i...
- Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
- Observation of Gravitational Waves from a Binary Black Hole Merger.
Schools
Boston University School Of Medicine
Framingham Union Hospital
Wilmer Opthalmological Institute
Harvard Med School
Procedures Preformed
- Cataract Removal Surgery
- Destruction of Lesion of Retina and Choroid
- Eyelid Surgery
- Repair of Retinal Detachment or Retinal Tear
Conditions Treated
- Age-Related Macular Degeneration
- Aphakia and Other Disorders of Lens
- Astigmatism
- Benign Neoplasm of Choroid
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FAAO)
Education
-
Johns Hopkins University -
Boston University School of Medicine
Hospital
-
Brigham and Women's Hospital -
Massachusetts Eye and Ear Infirmary -
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1588622104 | |
| NPPES Provider LastName | AIELLO | |
| NPPES Provider FirstName | LLOYD | |
| NPPES Provider ZIPCode | 02215 | |
| NPPES Provider State | MA | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 14.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588622104 |
| Last Name Of The Provider | AIELLO |
| First Name Of The Provider | LLOYD |
| View All |
Similar Doctors
|
|
Dr. Aimee R. Edell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Crandall E. Peeler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Avni V. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bobeck S. Modjtahedi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aubrey L. Gilbert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Rhoades, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mrinali M. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Boris Dilman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Savannah E. Baril, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Husam M. Ansari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melanie A. Kazlas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jules L. Baum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brooke Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elvia Canseco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony Joseph, MD |